Esperance Pharmaceuticals, Inc.
http://www.esperancepharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Esperance Pharmaceuticals, Inc.
Pipeline Watch: Kisqali, SI-6603, Cosentyx Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Execs On The Move, May 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Execs On The Move, April 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Venture Funding Deals, January 2015
Derived from Strategic Transactions, a premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2014.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice